We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

13 hedge funds and large institutions have $3.04M invested in Achieve Life Sciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

440% more capital invested

Capital invested by funds: $564K → $3.04M (+$2.48M)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0.75% more ownership

Funds ownership: 0.28% → 1.02% (+0.75%)

19% less funds holding

Funds holding: 16 → 13 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.46M
2
CH
CVI Holdings
Delaware
+$729K
3
RCM
Requisite Capital Management
Texas
+$399K
4
MFG
Magnus Financial Group
New York
+$13.9K
5
Northern Trust
Northern Trust
Illinois
+$6.78K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$85.2K
2
Citadel Advisors
Citadel Advisors
Florida
-$46K
3
Barclays
Barclays
United Kingdom
-$37K
4
Millennium Management
Millennium Management
New York
-$17K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$1.45M +$1.46M +182,927 New
CH
2
CVI Holdings
Delaware
$726K +$729K +91,463 New
RCM
3
Requisite Capital Management
Texas
$397K +$399K +50,000 New
Renaissance Technologies
4
Renaissance Technologies
New York
$198K -$85.2K -10,693 -30%
Vanguard Group
5
Vanguard Group
Pennsylvania
$141K – – –
SC
6
Searle & Co
Connecticut
$45K – – –
UBS Group
7
UBS Group
Switzerland
$37K +$5.32K +667 +17%
Northern Trust
8
Northern Trust
Illinois
$16K +$6.78K +851 +72%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$14K – – –
MFG
10
Magnus Financial Group
New York
$14K +$13.9K +1,750 New
BlackRock
11
BlackRock
New York
$4K – – –
Citadel Advisors
12
Citadel Advisors
Florida
– -$46K -7,011 Closed
Barclays
13
Barclays
United Kingdom
– -$37K -5,671 Closed
Millennium Management
14
Millennium Management
New York
– -$17K -2,620 Closed
Two Sigma Advisers
15
Two Sigma Advisers
New York
– -$17K -2,605 Closed
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
– -$7K -1,054 Closed
Victory Capital Management
17
Victory Capital Management
Texas
– -$4K -535 Closed
Bank of America
18
Bank of America
North Carolina
– -$2K -351 Closed
Wells Fargo
19
Wells Fargo
California
– +$24 +3 +38%

ACHV Hedge Fund Activity: Q2 2020 in Review

13 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2020, worth a combined $3.04M — up 440% from $564K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ACHV and 4 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.46M. The largest seller was Renaissance Technologies, cutting an estimated $85.2K.

  • 13 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2020, down from 16 in Q1 2020.
  • Funds reported $3.04M of Achieve Life Sciences stock for Q2 2020, up 440% quarter-over-quarter.
  • 4 funds opened new Achieve Life Sciences positions in Q2 2020 and 7 closed out, a net change of -3 holders.
  • The largest Achieve Life Sciences buyer in Q2 2020 was Ikarian Capital, an estimated $1.46M added.
  • The largest Achieve Life Sciences seller in Q2 2020 was Renaissance Technologies, an estimated $85.2K sold.

Based on aggregated 13F filings for Q2 2020.